Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125258204 | 12525820 | 4 | F | 20160726 | 20160705 | 20160729 | EXP | GB-009507513-1607GBR000703 | MERCK | 50.00 | YR | F | Y | 0.00000 | 20160729 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125258204 | 12525820 | 1 | SS | APREPITANT. | APREPITANT | 1 | Oral | STRENGTH: | U | U | 0 | CAPSULE | |||||||
| 125258204 | 12525820 | 2 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | UNK | U | U | 12675 | TABLET | |||||||
| 125258204 | 12525820 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125258204 | 12525820 | 4 | SS | PALONOSETRON HYDROCHLORIDE. | PALONOSETRON HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125258204 | 12525820 | 5 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125258204 | 12525820 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125258204 | 12525820 | 7 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125258204 | 12525820 | 8 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125258204 | 12525820 | 1 | Product used for unknown indication |
| 125258204 | 12525820 | 2 | Product used for unknown indication |
| 125258204 | 12525820 | 3 | Product used for unknown indication |
| 125258204 | 12525820 | 4 | Product used for unknown indication |
| 125258204 | 12525820 | 5 | Product used for unknown indication |
| 125258204 | 12525820 | 6 | Product used for unknown indication |
| 125258204 | 12525820 | 7 | Product used for unknown indication |
| 125258204 | 12525820 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125258204 | 12525820 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125258204 | 12525820 | Abdominal discomfort | |
| 125258204 | 12525820 | Alopecia | |
| 125258204 | 12525820 | Application site mass | |
| 125258204 | 12525820 | Asthenia | |
| 125258204 | 12525820 | Diarrhoea | |
| 125258204 | 12525820 | Nausea | |
| 125258204 | 12525820 | Neutropenia | |
| 125258204 | 12525820 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |